This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2491) Artificial Intelligence (1421) Chatbots and Conversational Agents (543) Computer-Aided Diagnosis (135) Breast Cancer (213) Innovations and Technology for Cancer Prevention and Screening (150) Innovations in Cancer Diagnostic and Decision Support (58) Patient Education for Cancer (154)

Published on in Vol 5, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25184, first published .
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Authors of this article:

Ann Sato1 Author Orcid Image ;   Eri Haneda1 Author Orcid Image ;   Nobuyasu Suganuma2 Author Orcid Image ;   Hiroto Narimatsu1, 3, 4 Author Orcid Image
Article Authors Cited by (15) Tweetations (5) Metrics

Journals

  1. Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S, Kohagura K, Matsubara Y, Sugawara Y, Yamanaka T, Yamashita T, Shimizu S, Narimatsu H. Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer. International Journal of Environmental Research and Public Health 2022;19(10):6182 View
  2. Walters N, Lindsey-Mills Z, Brangan A, Savage S, Schmidlen T, Morgan K, Tricou E, Betts M, Jones L, Sturm A, Campbell-Salome G. Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study. PEC Innovation 2023;2:100134 View
  3. Luca S, Clausen M, Shaw A, Lee W, Krishnapillai S, Adi-Wauran E, Faghfoury H, Costain G, Jobling R, Aronson M, Liston E, Silver J, Shuman C, Chad L, Hayeems R, Bombard Y, Bernier F, Brudno M, Carroll J, Cohn R, Dhalla I, Friedman J, Hewson S, Jamieson T, Kodida R, Laberge A, Lerner-Ellis J, Mamdani M, Marshall C, Osmond M, Pham Q, Reble E, Rudzicz F, Seto E, Shastri-Estrada S, Smith M, Thorpe K, Ungar W. Finding the sweet spot: a qualitative study exploring patients’ acceptability of chatbots in genetic service delivery. Human Genetics 2023;142(3):321 View
  4. Avila F, Boczar D, Spaulding A, Quest D, Samanta A, Torres-Guzman R, Maita K, Garcia J, Eldaly A, Forte A. High Satisfaction With a Virtual Assistant for Plastic Surgery Frequently Asked Questions. Aesthetic Surgery Journal 2023;43(4):494 View
  5. Wang A, Qian Z, Briggs L, Cole A, Reis L, Trinh Q. The Use of Chatbots in Oncological Care: A Narrative Review. International Journal of General Medicine 2023;Volume 16:1591 View
  6. Shane-Carson K, Smith D, Smith A, Seeley C. Retrospective chart analysis to determine the impact of a patient-facing digital risk stratification tool combined with a clinical screener for hereditary cancer genetic risk assessment triage in a community oncology clinic. Journal of Community Genetics 2023;15(1):25 View
  7. Rana H, Stopfer J, Weitz M, Kipnis L, Koeller D, Culver S, Mercado J, Gelman R, Underhill-Blazey M, McGregor B, Sweeney C, Petrucelli N, Kokenakes C, Pirzadeh-Miller S, Reys B, Frazier A, Knechtl A, Fateh S, Vatnick D, Silver R, Kilbridge K, Pomerantz M, Wei X, Choudhury A, Sonpavde G, Kozyreva O, Lathan C, Horton C, Dolinsky J, Heath E, Ross T, Courtney K, Garber J, Taplin M. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial. JCO Oncology Practice 2023;19(11):1069 View
  8. Savage S, LoTempio J, Smith E, Andrew E, Mas G, Kahn-Kirby A, Délot E, Cohen A, Pitsava G, Nussbaum R, Fusaro V, Berger S, Vilain E. Using a chat-based informed consent tool in large-scale genomic research. Journal of the American Medical Informatics Association 2024;31(2):472 View
  9. Thibaut G, Dabbagh A, Liverneaux P. Does Google’s Bard Chatbot perform better than ChatGPT on the European hand surgery exam?. International Orthopaedics 2024;48(1):151 View
  10. Rothstein M. Should Chatbots Be Used to Obtain Informed Consent for Research?. Ethics & Human Research 2023;45(6):46 View
  11. Wen K, Dayaratna S, Slamon R, Granda-Cameron C, Tagai E, Kohler R, Hudson S, Miller S. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study. Translational Behavioral Medicine 2024;14(1):1 View
  12. Kaphingst K, Kohlmann W, Lorenz Chambers R, Bather J, Goodman M, Bradshaw R, Chavez-Yenter D, Colonna S, Espinel W, Everett J, Flynn M, Gammon A, Harris A, Hess R, Kaiser-Jackson L, Lee S, Monahan R, Schiffman J, Volkmar M, Wetter D, Zhong L, Mann D, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S. Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models. JAMA Network Open 2024;7(9):e2432143 View
  13. Nguyen M, Sedoc J, Taylor C. Usability, Engagement, and Report Usefulness of Chatbot-Based Family Health History Data Collection: Mixed Methods Analysis. Journal of Medical Internet Research 2024;26:e55164 View
  14. Sato A, Haneda E, Hiroshima Y, Narimatsu H. Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study. Journal of Medical Internet Research 2024;26:e48914 View

Books/Policy Documents

  1. Félix B, Ribeiro J. Chatbot Research and Design. View